MRSN - Mersana Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MRSN is currently covered by 3 analysts with an average price target of $3.9. This is a potential upside of $-5.68 (-59.29%) from yesterday's end of day stock price of $9.58.

Mersana Therapeutics's activity chart (see below) currently has 6 price targets and 17 ratings on display. The stock rating distribution of MRSN is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 57.08% with an average time for these price targets to be met of 368 days.

Highest price target for MRSN is $36, Lowest price target is $3, average price target is $23.

Most recent stock forecast was given by ASTHIKA GOONEWARDENE from TRUIST on 13-Aug-2025. First documented stock forecast 15-Feb-2018.

Currently out of the existing stock ratings of MRSN, 5 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$36

$26.22 (268.10%)

$10

2 months 19 days ago
(13-Aug-2025)

1/2 (50%)

$28.58 (385.18%)

25

Buy

$30

$20.22 (206.75%)

$5

2 months 19 days ago
(13-Aug-2025)

0/2 (0%)

$22.58 (304.31%)

Buy

$3

$-6.78 (-69.33%)

5 months 27 days ago
(05-May-2025)

1/2 (50%)

$-4.93 (-62.17%)

585

1 years 8 months 3 days ago
(29-Feb-2024)

1/3 (33.33%)

$10.19 (175.39%)

28

1 years 8 months 3 days ago
(29-Feb-2024)

0/2 (0%)

$10.19 (175.39%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MRSN (Mersana Therapeutics) average time for price targets to be met?

On average it took 368 days on average for the stock forecasts to be realized with a an average price target met ratio 57.08

Which analyst has the current highest performing score on MRSN (Mersana Therapeutics) with a proven track record?

MICHAEL ULZ

Which analyst has the most public recommendations on MRSN (Mersana Therapeutics)?

Michael Ulz works at MORGAN STANLEY and has 2 price targets and 3 ratings on MRSN

Which analyst is the currently most bullish on MRSN (Mersana Therapeutics)?

Asthika Goonewardene with highest potential upside - $26.22

Which analyst is the currently most reserved on MRSN (Mersana Therapeutics)?

David Nierengarten with lowest potential downside - -$6.78

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?